Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid. - Wikidata - wikimedia - TriplyDB

Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid.

Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid.

http://www.wikidata.org/entity/Q37237399

about

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD Biological markers of Alzheimer's disease Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications Brain imaging in Alzheimer disease Beta-amyloid deposition and the aging brain Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Efavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND).Preoperative cerebrospinal fluid β-Amyloid/Tau ratio and postoperative delirium.Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.Cerebrospinal fluid biomarkers of Alzheimer's disease.In vivo human amyloid imaging.Reduced CSF turnover and decreased ventricular Aβ42 levels are related Soluble amyloid-β levels and late-life depression Cerebrospinal fluid analysis should be considered in patients with cognitive problems Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotype Plasma based markers of [11C] PiB-PET brain amyloid burden.Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.Emerging biomarkers in cognition.Biomarkers in Alzheimer's disease.Plasma Aβ and PET PiB binding are inversely related in mild cognitive impairment.Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.A consensus in Korea regarding a protocol to reduce preanalytical sources of variability in the measurement of the cerebrospinal fluid biomarkers of Alzheimer's disease.Beta-amyloid peptide variants in brains and cerebrospinal fluid from amyloid precursor protein (APP) transgenic mice: comparison with human Alzheimer amyloid.Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development.Evidence for ordering of Alzheimer disease biomarkers Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer's disease subjects.Fluid biomarkers in Alzheimer disease.

P2860

Q24594531-20F1A949-F689-471D-86A7-A289CF550ED8 Q26801666-A91C7900-9898-44FB-9C44-AC0DA49E74B1 Q26823847-C71E3B35-6042-4E60-A369-F708D0624BA4 Q26995267-3C7E9D17-9A2C-4ACA-877D-E9A227EA62FD Q26996299-BBF1E44A-1D62-498F-934A-A430286EB762 Q28264556-1CB25967-8227-4A3C-BC9D-4A33592F4663 Q28273817-C3AE3D6F-BE23-4491-9B92-BC5F060D2F21 Q28743561-367673D5-FB68-417F-BF74-C3B5229670F9 Q29614407-115F43FA-35BA-4DE7-869E-00EE67D7908C Q30557695-20AF6745-A571-4378-82EA-778A02CDB1DA Q30845482-8E1AB015-9C2A-4A1E-AC74-614AA58FAB5A Q31159582-2A0594E5-3C0F-41BB-AEEB-8621865C0812 Q33644582-1E32E5D6-0940-47D8-875B-363BFB86D785 Q33687554-EB2747A9-85B2-4602-9B59-9BA2E2C28AF4 Q33757828-D23B6B33-E76B-431F-9947-841D6A1603C7 Q33790277-78032352-7A0F-4D02-A6D0-B1795835ABAA Q33898968-F57F1AF0-1394-40B2-87F9-7AF106F0447B Q33933220-AF573560-FBF3-4CD0-A38D-9DB1585B8E3E Q34026659-7AAE4347-B69A-4381-9CAB-945751EEF66F Q34247849-82C8CDB2-FC24-4D91-85A4-1929417DAA05 Q34363475-9AAA4665-10C9-41C8-9C0C-5E15BFF874BC Q34427001-C0EBE910-0DBC-421E-92B2-69C238528818 Q34493453-28E1ED2F-8C50-4048-8CB2-59EB50E92300 Q34606568-C3D1A29A-EA7D-4544-9105-943BC517C52B Q34699437-B7DA23D0-DFE7-45F8-BC2D-D3382BF21F08 Q34735454-D072ACD4-A597-438E-AFB8-36E04BD5183A Q35008258-3CE64EF9-D85D-4358-A987-E571B5B97829 Q35113795-7F4347A4-8D02-4D2F-8ED1-364CB9DE4B72 Q35117068-15341B26-9326-4AB6-B14C-3B3E05BE8902 Q35119389-4B9CD3C9-C927-4E99-8EEB-B4650C4001A4 Q35158547-6A484CB8-940F-47EE-AFD8-E21030F3B15E Q35161042-55A4A830-577B-402D-B36A-86EEEF351EE2 Q35218413-0C3CD814-8729-4FFB-B27C-81B49426E13B Q35291150-F8A1AAA4-1108-4525-814B-EE93F207CBDF Q35311113-AA9E292A-3E8C-4B77-8CA9-C044C9B6FF70 Q35600979-04FE3558-F4A2-40F0-85F6-C4855B31C3DC Q35840623-331B4E5C-52EA-4780-8983-9B443CA85B35 Q36071403-572FB6A6-0DFD-4FA7-90C4-7AA509786F9D Q36173392-76E376DF-73E5-4A51-AEC2-7A6E57D16F4D Q36186513-B1F8E8AD-1B62-4D9D-8B87-D2FE49C573BB

P2860

Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid.

http://www.wikidata.org/entity/Q37237399

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Beta amyloid in Alzheimer's di ...... ration in cerebrospinal fluid.

@en

Beta amyloid in Alzheimer's di ...... ration in cerebrospinal fluid.

@nl

type

label

Beta amyloid in Alzheimer's di ...... ration in cerebrospinal fluid.

@en

Beta amyloid in Alzheimer's di ...... ration in cerebrospinal fluid.

@nl

prefLabel

Beta amyloid in Alzheimer's di ...... ration in cerebrospinal fluid.

@en

Beta amyloid in Alzheimer's di ...... ration in cerebrospinal fluid.

@nl

P1433

Q37237399-9A997D1A-5BBA-4761-9419-C6559AA16043

P1476

Q37237399-FEC7BC94-0AD3-4116-94B8-2D4F60D63FC7

P2093

Q37237399-576AFB4F-1D45-4629-8EE1-1354F903E3A6

Q37237399-8140B0E6-96F2-4F5D-8EA5-82CBE9B3D495

Q37237399-B1FB8B4B-5A17-451C-9273-82BDA761080A

Q37237399-BA9E1168-63DE-4A4F-8803-8FD7F07E6048

Q37237399-C2A3326D-7734-4A3B-9F14-94F3E1130A9E

Q37237399-CDE665F1-6D31-4705-993E-1A247E353EB9

Q37237399-F22E4BF5-B75E-414B-9EAF-6D0E20628379

Q37237399-FDCA04FE-7E1C-408A-82D8-B02E315AA0A2

P2860

Q37237399-02775D48-3C43-46B7-93B7-8461BE2F8A78

Q37237399-028A887E-05C9-4DE1-BAE0-B411D7F28C4F

Q37237399-08D72430-8E17-49B9-8050-F92B6A30EAE2

Q37237399-0D908E63-34F0-4B81-8273-97C4855A1CA5

Q37237399-0E3312B6-A445-4C3F-8DAD-50CEBE4C6A91

Q37237399-11479A0A-1831-431C-BDE0-7133E75C4F6A

Q37237399-23BAB14C-2C73-49DB-B8EE-D865BCCABF99

Q37237399-2A70EC81-ABB4-409E-A298-1C8A4030A850

Q37237399-2DC74D51-E0B2-42A8-A492-0C6600F76288

Q37237399-401F3B1E-79D7-42BB-81E0-C585D9822189

P304

Q37237399-532A400E-F746-457B-803C-1F67BCA40A5B

P31

Q37237399-D8F2EE5D-1823-4D51-87C0-1664408EF24B

P356

Q37237399-7A22FD6C-38BC-40CC-A57D-B98B68223FC2

P407

Q37237399-8116746C-5947-404F-B977-AA1D234726E6

P433

Q37237399-7CBC544D-F1FE-488B-BB81-26B50FA6679D

P478

Q37237399-25AD0A0E-96C8-4A6D-8EF1-9E2E2D137DD4

P50

Q37237399-8615EE4B-F5B8-47D4-BAE3-7763BB287B30

Q37237399-A577D360-380F-4DAF-B84A-7E8204ED581F

P577

Q37237399-BAEA1B41-970B-4329-A6A4-A42700A67C03

P5875

Q37237399-09AF0258-B9B3-49D7-B51E-72F6A9AE71EB

P698

Q37237399-8F922727-3E39-475E-9993-F43E968516A3

P921

Q37237399-C9C79EAE-870E-4214-B716-88D2D19FDD95

Q37237399-D2D1C763-1A1C-46DE-8F33-5DB2B7EA7A38

P932

Q37237399-A4E7A6AD-9A14-42DE-A6FD-68B56B643A5D

P356

J.BIOPSYCH.2009.01.027

P1433

Biological Psychiatry

P1476

Beta amyloid in Alzheimer's di ...... ration in cerebrospinal fluid.

@en

P2093

Alexander Kurz

http://www.w3.org/2001/XMLSchema#string

Chester A Mathis

http://www.w3.org/2001/XMLSchema#string

Gjermund Henriksen

http://www.w3.org/2001/XMLSchema#string

Hans Förstl

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Wester

http://www.w3.org/2001/XMLSchema#string

Matthias Riemenschneider

http://www.w3.org/2001/XMLSchema#string

Timo Grimmer

http://www.w3.org/2001/XMLSchema#string

Tohru Shiga

http://www.w3.org/2001/XMLSchema#string

P2860

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

CSF markers for incipient Alzheimer's disease.

Imaging Alzheimer's disease: clinical applications.

P304

927-934

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2009.01.027

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

William E. Klunk

Alexander Drzezga

P577

2009-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24184462

http://www.w3.org/2001/XMLSchema#string

P698

19268916

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

P932

2700302

http://www.w3.org/2001/XMLSchema#string